
09/15/2025
Thank you to Senate appropriators for recognizing the transformative potential of cell and gene therapies in their FY26 funding recommendations. The $400M increase and targeted provisions - from expanding transplant access to addressing manufacturing challenges - will directly benefit patients awaiting breakthrough treatments.